Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Sep 24, 2020 7:03 AM ET

United States Non-Invasive Prenatal Testing Market is anticipated to grow over US$ 2.2 Billion by 2027


iCrowd Newswire - Sep 24, 2020

United States Non-Invasive Prenatal Testing Industry

New Study Reports “Non-Invasive Prenatal Testing Market 2020 United States Market Opportunities, Challenges, Strategies and Forecasts 2027” has been Added on WiseGuyReports.

The United States Non-Invasive Prenatal Testing market is anticipated to grow over US$ 2.2 Billion by 2027.

The growth in the U.S. Non-Invasive Prenatal Testing (NIPT) market is largely attributed to factors such as the high risk of chromosomal abnormalities with increasing maternal age, increase in incidences of chromosomal aneuploidies among fetus, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing, rising focus on reimbursement for NIPT, increasing preference for non-invasive techniques over invasive methods and ACOG guidelines recommend NIPT for all pregnancies regardless of risk.

Key Findings:
• The United States Rises to Become Largest NIPT Test Market
• The U.S. NIPT Test Market is Expected to Register a CAGR of More Than 18% during 2020 -2027
• Harmony, Verifi and Panorama are the Most Popular NIPT Test Available in the United States

Try Free Sample of United States Non-Invasive Prenatal Testing Market @   https://www.wiseguyreports.com/sample-request/5868894-u-s-non-invasive-prenatal-testing-market-growth

Key Features of the Study:

• The Market Size of the United States Non–Invasive Prenatal Testing Market with Seven Years Forecast
• The Market Size of the United States Average Risk Non–Invasive Prenatal Testing Market with Seven Years Forecast
• The Market Size of the United States High Risk Non–Invasive Prenatal Testing Market with Seven Years Forecast
• Analyses the Number of NIPT Tests Performed in the United States with Seven Years Forecast
• Examines the United States Number of Average Risk NIPT Tests Performed with Seven Years Forecast
• Scrutinizes the United States Number of High Risk NIPT Tests Performed with Seven Years Forecast
• Assessment of Market Potential and Opportunities for this Innovation-Driven United States Non–Invasive Prenatal Testing Market with Seven Years Forecast
• Insight into the United States Average and High-Risk Potential NIPT Tests Market with Seven Years Forecast
• Meticulously Assesses the Overall United States Potential Non–Invasive Prenatal Testing (NIPT) Volume and Future Trends
• Analyses of the United States Average and High-Risk Potential Number of Tests Performed with Seven Years Forecast
• Detailed Insights into the Regulatory Framework of the United States Non–Invasive Prenatal Testing Market
• Features Reimbursement Patterns of the United States Non–Invasive Prenatal Testing Market
• Tracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions. Collaboration, Distribution, Exclusive and Licensing Agreement
• A Comprehensive List of the Key Players Along with the Analysis of their Current NIPT Test Portfolios, Business

Key factors influencing the market

A broad range of factors has been highlighted in the report that influences the performance and expansion of the United States Non-Invasive Prenatal Testing Market. An in-depth analysis of the pricing history relating to the product or service is presented, in addition to the value of the offering and the volume trend. Some of the key factors that have been emphasized in the report include the influence of the expanding population at the United States level, the rapid advancement of technological innovation, and the demand and supply dynamics relating to the United States Non-Invasive Prenatal Testing Market. The report also assesses the implication of different government initiatives and the competitive intensity in the market during the forecasted period.

Evaluation of Market segmentation

The thorough segmentation of the United States Non-Invasive Prenatal Testing Market is presented and explained in the report. The categorization has been done on the basis of a broad range of aspects, including regional segmentation. The segmentation of the market has helped to get a detailed and integrated insight into the market and the factors that operate in it. Some of the key geographical segments that have been elaborated in detail in the report include Europe, North America, Latin America, the Middle East, and Africa, and the Asia Pacific.

The Key Market Players for the United States Non–Invasive Prenatal Testing Market Are Listed Below:
• Illumina
• Natera
• Quest Diagnostics
• Myriad Genetics
• Centogene
• GenPath
• Progenity
• PerkinElmer
• Yourgene Health
• Invitae Corporation
• Agilent Technologies
• Ariosa Diagnostics (Roche)
• Integrated Genetics (LabCorp)

Research Method

The thorough research of the United States Non-Invasive Prenatal Testing Market has been carried out by the competent market research team by using a diverse range of tools and techniques. Porters’ Five force model has been used to analyse the competitive intensity in the United States Non-Invasive Prenatal Testing Market for the assessment period of 2020 to 2027. SWOT analytical framework has been used to capture the micro and macro factors that come into play and influence the business in the industrial setting. The objective is to assist the readers in getting a holistic insight into the United States Non-Invasive Prenatal Testing Market.

Chief market players

The report focuses on different vendors that are present in the United States Non-Invasive Prenatal Testing Market. The strategies that are deployed by these market players to get an edge over their rivals and expand their reach in the market have been evaluated thoroughly.

Key Questions Addressed by the Report
• What is the current size of the overall non–invasive prenatal testing market in the United States?
• How much will this market be worth from 2020 to 2027?
• How has the potential market performed so far and how will it perform in the coming years?
• How many NIPT tests being performed in the U.S. during 2015 – 2027?
• What is the market size of the average risk NIPT tests market in the United States?
• What is the market size of the high risk NIPT tests market in the United States?
• What are the key marketed NIPT tests available in the United States?
• What are the major drivers of the United States non–invasive prenatal testing market?
• What are the major inhibitors of the United States non–invasive prenatal testing market?
• What is the reimbursement pattern in the United States non–invasive prenatal testing market?
• What is the regulatory framework in the United States non–invasive prenatal testing market?
• What are the major deals and agreement happenings in the United States non–invasive prenatal testing market?
• Who are the top market players? What are their happenings, current developments, and scenarios?
• How is the market predicted to develop in the future?

If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/5868894-u-s-non-invasive-prenatal-testing-market-growth

Some points from table of content:

1. Executive Summary
2. United States Actual Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2015 – 2027)
3. United States Potential Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2015 – 2027)
4. United States Actual Non–Invasive Prenatal Testing Market Size and Forecast (2015 – 2027)
5. United States Potential Non–Invasive Prenatal Testing Market Size and Forecast (2015 – 2027)
6. United States Non–Invasive Prenatal Testing Market Drivers and Inhibitors
7. Non–Invasive Prenatal Testing Comparative Analysis
8. Reimbursement Environment of the United States Non-Invasive Prenatal Testing
9. Regulation Framework of the United States Non-Invasive Prenatal Testing
10. Major Deals and Agreements in the Non–Invasive Prenatal Testing Market
11. Key Companies Analysis
11.1 Integrated Genetics (LabCorp)
11.1.1 Business Overview
11.1.2 Product Outlook
11.1.3 Key Developments
11.2 Yourgene Health
11.2.1 Business Overview
11.2.2 Product Outlook
11.2.3 Key Developments
11.3 Ariosa Diagnostics (Roche)
11.3.1 Business Overview
11.3.2 Product Outlook
11.3.3 Key Developments
11.4 Illumina
11.4.1 Business Overview
11.4.2 Product Outlook
11.4.3 Key Developments
11.5 Natera
11.5.1 Business Overview
11.5.2 Product Outlook
11.5.3 Key Developments
11.6 Quest Diagnostics
11.6.1 Business Overview
11.6.2 Product Outlook
11.6.3 Key Developments
11.7 Myriad Genetics
11.7.1 Business Overview
11.7.2 Product Outlook
11.7.3 Key Developments
11.8 Centogene
11.8.1 Business Overview
11.8.2 Product Outlook
11.8.3 Key Developments
11.9 Invitae Corporation
11.9.1 Business Overview
11.9.2 Product Outlook
11.9.3 Key Developments
11.10 GenPath
11.10.1 Business Overview
11.10.2 Product Outlook
11.10.3 Key Developments
11.11 Progenity
9.11.1 Business Overview
11.11.1 Product Outlook
11.11.2 Key Developments
11.12 PerkinElmer
11.12.1 Business Overview
11.12.2 Product Outlook
11.12.3 Key Developments
11.13 Agilent Technologies
11.13.1 Business Overview
11.13.2 Product Outlook
11.13.3 Key Developments

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

 



Contact Information:

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn:
https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym






Keywords:    Non-Invasive Prenatal Testing industry, Non-Invasive Prenatal Testing market trends, Non-Invasive Prenatal Testing industry trends, Non-Invasive Prenatal Testing market growth, Non-Invasive Prenatal Testing market size, Non-Invasive Prenatal Testing manufacturer, United States Non-Invasive Prenatal Testing industry, United States Non-Invasive Prenatal Testing market trends, Non-Invasive Prenatal Testing growth, United States Non-Invasive Prenatal Testing market share covid-19

Tags:    IPS, Reportedtimes, iCN Internal Distribution, Research Newswire, English